An EORTC study published in Lancet Oncology found that health-related quality of life (HRQOL) assessment in small-cell lung cancer randomized clinical trials provides relevant added information in studies where the treatment ...
Jan 28, 2014
0
0
Long term results of the randomized phase III EORTC intergroup trial 40983 were recently reported in The Lancet Oncology. The observed 4.1% difference in overall survival at five years for patients with initially resectable ...
Nov 6, 2013
0
0
The study, published in The Lancet Oncology, is the first ever assessment of the effect of cancer screening in rural sub-Saharan Africa, and the authors are hopeful that their work, which is on-going, will ultimately show ...
Jan 30, 2013
0
0
In a Comment linked to The Lancet Physics Series, Dr Ahmed Meghzifene (Division of Human Health, International Atomic Energy Agency, Vienna, Austria) cautions that only physicists with the correct clinical training should ...
Apr 17, 2012
0
0
Having Huntington's disease or other diseases known as polyglutamine (polyQ) diseases reduces a person's risk of getting cancer, suggesting a common genetic mechanism, concludes an Article published Online First by The Lancet ...
Apr 11, 2012
0
0
Women who use the oestrogen-only form of hormone replacement therapy (HRT) appear less likely to develop breast cancer in the longer term, according to new research published Online First in The Lancet Oncology. A follow-up ...
Mar 6, 2012
0
0
Hot flushes and night sweats (HFNS) affect 65-85% of women after breast cancer treatment; they are distressing, causing sleep problems and decreased quality of life. Hormone replacement therapy is often either undesirable ...
Feb 14, 2012
0
0
A drug that has been shown to prevent breast cancer in postmenopausal women at high risk of developing the disease, and is poised for widespread use, appears to significantly worsen age-related bone loss, according to an ...
Feb 6, 2012
0
0
Blocking the action of vascular endothelial growth factor (VEGF) with the new anti-VEGF drug aflibercept can curb the development of malignant ascites (excessive fluid in the abdomen), a common and painful complication of ...
Dec 20, 2011
0
0
Cancer is one of the leading causes of death and morbidity worldwide, and its economic burden grows year by year. In 2008, the worldwide cost of cancer due to premature death and disability, excluding direct medical costs, ...
Sep 26, 2011
0
0
